Gregory A. Rippon, MD, MS
Advertisement
Chief medical partner of neurology, ophthalmology, and internal medicine at Genentech
Articles by Gregory A. Rippon, MD, MS
The chief medical partner of neurology, ophthalmology, and internal medicine at Genentech shared his perspective on the steps the field has taken to improve clinical trials and therapies for neurodegenerative diseases such as Alzheimer disease. [WATCH TIME: 3 minutes]
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Orexin Agonist Oveporexton for Narcolepsy Type 1
2
FDA Accepts SL1009 Resubmission for PDCD, Sets December PDUFA Date
3
FDA Grants RMAT Designation to Sasineprocel for Parkinson Disease
4
High-Dose N-Acetyl Cysteine Associated With Reduced GFAP Levels in Phase 2 Progressive MS Study
5